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Cells of the trophoblast lineage make up the epithelial compartment of the placenta, and their rapid development is essential for the
establishment and maintenance of pregnancy. A diverse array of specialized trophoblast subtypes form throughout gestation and are
responsible for mediating implantation, as well as promotion of blood to the implantation site, changes in maternal physiology, and nutrient
and gas exchange between the fetal and maternal blood supplies. Within the last decade, targeted mutations in mice and the study of
trophoblast stem cells in vitro have contributed greatly to our understanding of trophoblast lineage development. Here, we review recent
insights into the molecular pathways regulating trophoblast lineage segregation, stem cell maintenance, and subtype differentiation.
D 2005 Elsevier Inc. All rights reserved.Keywords: Trophoblast lineage; Subtype specification; Mouse placenta; Stem cell maintenanceIntroduction
The placenta is the first organ to form in the mammalian
embryo that promotes the survival and growth of the embryo
in the uterus of the mother. The trophoblast cell lineage
forms the epithelial part of the placenta and contains several
specialized cell subtypes that play roles either in altering
maternal physiology and blood flow to promote fetal growth
or in nutrient uptake. Over the past decade, considerable
insights have been gained into how the trophoblast lineage is
segregated at the blastocyst stage and its subsequent differ-
entiation, fueled largely by the generation of over 100 mutant
mouse lines that manifest defects in placental development.
In addition, the derivation of murine trophoblast stem cell
lines has provided a powerful resource for understanding the
molecular mechanisms governing trophoblast stem cell
maintenance and differentiation. This review will focus on
the current state of knowledge of trophoblast lineage
formation, stem cell maintenance, and the subsequent0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.05.010
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E-mail address: jcross@ucalgary.ca (J.C. Cross).differentiation of the numerous trophoblast subtypes that
make up the murine placenta.Early segregation and specification of trophoblast
lineage
The first cell fate decision during murine embryonic
development occurs at the 16-cell stage, where the polarized
outer cells which later give rise to the trophectoderm are
segregated from the apolar inner cells, the cells destined to
become the inner cell mass (ICM). It is not until the
blastocyst stage, however, that these cell fate decisions are
considered irreversible as cells of the late morula can still
adopt the opposite cell fate if their positions are reversed
within the embryo (Ziomek et al., 1982). These early inner
and outer cells can be distinguished not only by position but
also by the expression of molecular markers. For example,
the homeobox transcription factors Nanog (Chambers et al.,
2003; Mitsui et al., 2003) and Cdx2 (Kunath et al., 2004) are
differentially expressed within the inner apolar cells and
outer polarized cells of the late morula, respectively.284 (2005) 12 – 24
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Cdx2 null embryos form blastocysts but fail to maintain
trophectoderm cell identity, instead forming a ball of Oct4
expressing cells incapable of hatching from the zona
pellucida (Kunath et al., 2004). In addition, ectopic
expression of Cdx2 in embryonic stem cell (ES) cells is
sufficient to induce differentiation to the trophoblast cell
lineage in vitro (Niwa, 2003). Cdx2 is the earliest known
factor to have a role in trophoblast lineage development,
although the molecular targets mediating its role in
trophectoderm identity are still unknown.
In contrast to specifying trophectoderm identity, Nanog is
required to maintain ES cell self-renewal. Nanog-deficient
ES cells lose their pluripotency and differentiate into
endoderm (Mitsui et al., 2003), while overexpression of
Nanog can override the dependency on LIF/STAT signaling
for ES cell self-renewal, though pluripotency still requires
Oct4 activity (Chambers et al., 2003). Oct4, a POU domain
transcription factor, is also involved in ICM fate determi-
nation, although its expression does not become restricted
until the late blastocyst stage (Okamoto et al., 1990; Rosner
et al., 1990; Scholer et al., 1990), suggesting that it is not
involved in initial lineage segregation. However, Oct4 is
required to maintain ES cell fate and to suppress the
differentiation of the ICM and cultured ES cells into
trophectoderm derivatives (Nichols et al., 1998; Niwa et
al., 2000). Regulatory sequences of the Oct4 gene are
hypermethylated and associated with a closed chromatin
structure in trophoblast stem cells, whereas these regions are
hypomethylated with an open chromatin structure (acety-
lated histones) in ES cells, resulting in differential geneFig. 1. Overview of the trophoblast lineage and the expressiexpression (Hattori et al., 2004). Another transcription
factor, Sox2, has a similar function in repressing the
trophoblast cell fate as that observed for Oct4 (Avilion et
al., 2003) and works together with Oct4 to regulate down-
stream targets expressed in the ICM (Okuda et al., 1998).FGF4 signaling is required for maintenance of
trophoblast stem cells
The trophectoderm layer of the preimplantation embryo
is the precursor to all trophoblast cell subtypes (Fig. 1).
However, the entirety of the trophectoderm layer does not
contribute equally to the various trophoblast subtypes. Upon
implantation, the trophectoderm of the blastocyst not in
contact with the ICM, the mural trophectoderm, differ-
entiates to form post-mitotic primary trophoblast giant cells
(TGC) that migrate into the antimesometrial portion of the
implantation chamber and surround the future parietal yolk
sac. In contrast, the trophectoderm directly overlying the
ICM, known as the polar trophectoderm, retains its capacity
to proliferate and expands to form the extraembryonic
ectoderm and ectoplacental cone (Gardner et al., 1973).
Maintenance of trophoblast proliferation and self-renewal is
dependent on signals from the ICM. Indeed, ICM cells
inserted into an empty sphere of trophectoderm can induce
secondary sites of proliferation (Gardner et al., 1973).
Pluripotent trophoblast stem cells reside within the extra-
embryonic ectoderm and later the chorionic ectoderm
(Tanaka et al., 1998; Uy et al., 2002) and provide the
ectoplacental cone with progenitors which give rise to theon patterns of trophoblast cell subtype specific genes.
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trophoblast proliferation later in gestation is also dependant
on close proximity with the embryonic-derived epiblast as
isolated ectoplacental cone or extraembryonic ectoderm
transplanted ectopically (Hunt and Avery, 1976) or cultured
in vitro (Jenkinson and Billington, 1974; Rossant and Ofer,
1977) do not proliferate and in fact rapidly differentiate into
TGCs.
Molecular and genetic data indicate that FGF signaling
plays a major role in regulating trophoblast proliferation and
differentiation. Fgf4 is expressed in early embryos, becom-
ing restricted to the ICM of the blastocyst and later to the
epiblast of the early post-implantation embryo (Niswander
and Martin, 1992; Rappolee et al., 1994). In contrast, Fgfr2,
the receptor for FGF4, is reciprocally expressed in
trophectoderm and extraembryonic ectoderm (Haffner-
Krausz et al., 1999), strongly indicating that FGF4 may
promote trophoblast proliferation via FGFR2 signaling.
Genetic support for this came with the generation of mutant
mice. Fgf4-deficient embryos die shortly after implantation
(Feldman et al., 1995), likely resulting from a failure to
maintain trophectoderm and primitive endoderm identity
(Goldin and Papaioannou, 2003). In addition, the phenotype
of mice with a deletion of exon 9 of the Fgfr2 gene, which
deletes the IIIc isoform, resembles that of Fgf4 null mice
(Arman et al., 1998). Interestingly, a second Fgfr2 mutant
with a deletion of the exons 7–9, the whole Ig loop,
survives longer into gestation but dies of a defect in the
labyrinth layer of the placenta by E10.5 (Xu et al., 1998). It
is unclear whether the exon 9 deletion results in a dominant-
negative form of Fgfr2 or whether the exons 7–9 mutation
results in a hypomorphic allele. Mutation of the Fgfr2 IIIb
isoform results in perinatal death due to lung abnormalities
(De Moerlooze et al., 2000), indicating that FGF4 likely
signals through FGFR2 IIIc, and not IIIb, to promote
trophoblast proliferation.
In support of the importance of Fgf4, trophoblast stem
(TS) cell lines can be derived from both blastocysts and
E6.5 extraembryonic ectoderm by culturing in the presence
of FGF4 and embryonic fibroblast conditioned medium
(Tanaka et al., 1998). By removing FGF4 and embryonic
fibroblast conditioned medium, TS cells differentiate into
various trophoblast subtypes in culture (Hughes et al., 2004;
Tanaka et al., 1998). Importantly, if injected back into
blastocysts, TS cells retain the ability to differentiate into all
trophoblast subtypes (Tanaka et al., 1998).
The ERK1/2 MAP kinases have been shown to be
downstream effectors of FGF receptor signaling (Ornitz and
Itoh, 2001). Recently, two groups produced Erk2 mutant
mice that die shortly after implantation due to a lack of
ectoplacental cone and extraembryonic ectoderm formation
(Saba-El-Leil et al., 2003; Yao et al., 2003). Intriguingly, a
third group produced Erk2 mutant mice which survived
until E11.5 after which they died due to defects in placental
labyrinth development (Hatano et al., 2003). The prolonged
survival in these latter mice may be due to the generation ofa hypomorphic allele rather than a null mutation as the
mutation did not delete exon 2. Nevertheless, Erk2 is clearly
required for both maintenance of trophoblast proliferation in
the extraembryonic ectoderm and ectoplacental cone, as
well as subsequent development of the labyrinth layer of the
placenta.Nodal activity is essential for TS cell maintenance
While it is now well established that ICM- or epiblast-
derived FGF4 promotes proliferation of the extraembryonic
ectoderm through FGFR2 signaling, the initial attempts to
generate TS cell lines required the presence of unknown
factor(s) that could be provided by embryonic fibroblast
conditioned medium (Tanaka et al., 1998). Recent studies
have implicated several members of the TGFh superfamily
in this role, in particular Nodal.
Nodal plays an important role in trophoblast differ-
entiation as conceptuses with a hypomorphic allele of Nodal
have disrupted placental development characterized by the
absence of a labyrinth layer and expanded spongiotropho-
blast and TGC layers (Ma et al., 2001). A recent study has
served to clarify the role of Nodal in the maintenance of
trophoblast stem cells and to define in more detail the
Fmicroenvironment_ in which they reside (Guzman-Ayala et
al., 2004). The extraembryonic ectoderm expresses the
transcription factor genes Err2/Errb (Luo et al., 1997;
Pettersson et al., 1996; Tremblay et al., 2001), Eomesoder-
min (Eomes) (Ciruna and Rossant, 1999; Russ et al., 2000),
and Cdx2 (Chawengsaksophak et al., 1997; Kunath et al.,
2004) in response to FGF4 signaling and is required for the
maintenance of proliferation. Nodal acts in an autocrine
manner within the epiblast to maintain FGF4 expression but
also acts upon the extraembryonic ectoderm, with FGF4, to
sustain expression of Err2, Eomes, and Cdx2 and to
suppress expression of Mash2 (Guzman-Ayala et al.,
2004). In addition, extraembryonic ectoderm-derived Furin
and PACE4, secreted proteases that cleave Nodal into a
more active form (Beck et al., 2002), are also required for
maintenance of the extraembryonic ectoderm (Guzman-
Ayala et al., 2004). Based on this work, it is clear that
trophoblast stem cell maintenance is dependent upon cross-
talk between the epiblast and extraembryonic ectoderm
(Fig. 2).
In addition to Nodal, other members of the TGFh
superfamily can promote maintenance of extraembryonic
ectoderm in culture. Activin can maintain expression of
extraembryonic ectoderm markers and prevent ectopic
Mash2 expression in cultured extraembryonic ectoderm
(Guzman-Ayala et al., 2004). Activin can also replace
embryonic fibroblast conditioned medium for the main-
tenance of TS cell proliferation in vitro (Erlebacher et al.,
2004). In fact, TS cell lines can be established de novo in
medium supplemented with FGF4 and Activin (Erlebacher
et al., 2004). It may be that Activin simply mimics the
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signaling mechanisms (de Caestecker, 2004). Mutations in
the Nodal/Activin receptors Alk2 (Gu et al., 1999) and Alk4
(Gu et al., 1998), double mutants for Type II receptors Act
RII and Act RIIb (Song et al., 1999), and the downstream
signaling molecules Smad2 (Waldrip et al., 1998) and
Smad4 (Sirard et al., 1998) result in early defects similar to
those seen with Nodal and Furin/Pace4 mutant mice.
However, single mutant mice for Activin beta A (Matzuk
et al., 1995), B (Matzuk et al., 1995; Vassalli et al., 1994), C
(Lau et al., 2000), or double mutant mice for Activin beta
A/B (Matzuk et al., 1995) do not have phenotypes
resembling loss of FGF4 or Nodal. Based on these
observations, it may be that, while Activin can compensate
for Nodal through the use of shared receptors, it is not itself
essential for maintenance of extraembryonic ectoderm in
vivo. However, triple mutants have not yet been reported for
the Activin ligands.
TGFh can also replace embryonic fibroblast conditioned
medium in maintaining TS cells in vitro (Erlebacher et al.,
2004). TS cell lines passaged for more than 1.5 months in
the presence of FGF4 and TGFh (without embryonic
fibroblast conditioned medium) can still contribute to all
trophoblast cell subtypes in chimeric embryos (Erlebacher
et al., 2004). However, the physiological significance of
TGFh in maintaining trophoblast stem cell proliferation in
vivo remains to be clarified as neither TGFh ligand
(Goumans et al., 1999; Kaartinen et al., 1995; Proetzel etFig. 2. The trophoblast stem cell microenvironment. Diagrams depict mouse conce
maintenance of trophoblast stem cell proliferation. At E6.5, Fgf4 from the emb
expression and suppress Mash2 expression in the extraembryonic ectoderm. Nod
maintain trophoblast stem cell marker expression in extraembryonic ectoderm. Pa
more active form. At E7.5, Fgf4 and Nodal are expressed in distal embryonic ect
exocoelomic cavity. It is unclear how Fgf4/Nodal dependent trophoblast stem cel
stem cell maintenance at this stage is dependent upon factors within the ectoplacen
ectoderm, Light green—parietal endoderm, Dark green—visceral endoderm, Redal., 1995; Sanford et al., 1997) nor TGFh type II receptor
(Oshima et al., 1996) mutant mice have trophoblast
phenotypes.
The details of how FGF4 and TGFh superfamily ligands
(Nodal, Activin, or TGFh) cooperate to maintain tropho-
blast stem cell identity are now being elucidated. In the
absence of any growth factor, isolated extraembryonic
ectoderm explants undergo differentiation into ectoplacental
cone derivatives, upregulating Mash2 expression while
dowregulating Cdx2, Eomes, and Err2 (Guzman-Ayala et
al., 2004). The addition of FGF4 alone can inhibit the
induction of Mash2 but cannot maintain expression of
Cdx2, Eomes, and Err2. Conversely, addition of Nodal or
Activin alone cannot inhibit Mash2 expression in extra-
embryonic ectoderm but, in combination with FGF4, can
maintain Cdx2, Eomes, and Err2 expression (Guzman-
Ayala et al., 2004). These data indicate that FGF4 and Nodal
(or Activin or TGFh) have distinct but cooperative
functions in TS cell maintenance.Developmental loss of trophoblast stem cell potential
While TS cell lines can be derived from blastocysts
and early post-implantation extraembryonic ectoderm
(Tanaka et al., 1998), this potential disappears completely
by the 11 somite pair stage (Uy et al., 2002), which
corresponds to approximately E8.5–E8.75 (Kaufman andptuses at E6.5 and E7.5 indicating the molecular interactions required for the
ryonic ectoderm signals through Fgfr2 to sustain Cdx2, Eomes, and Err2
al from the epiblast maintains Fgf4 expression and cooperates with Fgf4 to
ce4 and Furin from extraembryonic ectoderm process Nodal into a mature
oderm which, at this stage, is separated from the chorion and Fgfr2 by the
ls are maintained at this and later stages. It is hypothesized that trophoblast
tal cavity. Blue—extraembryonic ectoderm (trophoblast), Gray—embryonic
—mesoderm.
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dependent upon contact of the allantois with the chorion,
although this event (approximately 5 somite pair stage)
corresponds to an initial drop in TS cell potential (Uy et
al., 2002). Instead, disappearance of TS cell potential
appears to be associated with the occlusion of the
ectoplacental cavity (Uy et al., 2002), the space formed
after the anterior and posterior amniotic folds meet to
produce the chorion and spatially separate it from the
ectoplacental cone (Kaufman and Bard, 1999). In cultures
of whole mouse conceptuses, removal of the ectoplacental
cone prior to chorion–ectoplacental fusion increases the
TS cell potential of extraembryonic ectoderm over that of
intact conceptuses (Uy et al., 2002). Based on this, factors
within the ectoplacental cavity fluid may contribute to
trophoblast stem cell maintenance at the later egg cylinder
stage rather than contact with the epiblast which has
ceased by this stage of development (Uy et al., 2002)
(Fig. 2). The finding that TS cell potential is lost by E8.5
has important developmental implications since the pla-
centa continues to grow almost until the end of term. It
may be that as yet uncharacterized progenitor cells are
formed that account for the development of the subse-
quent placental layers and various trophoblast subtypes
which comprise them.Trophoblast giant cell differentiation
Trophoblast giant cells are terminally differentiated,
polyploid cells that arise through the process of endoredu-
plication, an unusual cell cycle with successive rounds of
DNA synthesis in the absence of intervening mitoses
(Gardner and Davies, 1993; MacAuley et al., 1998). Since
they initially form at the periphery of the conceptus, they are
in contact with maternal tissue and blood at virtually every
stage of development and serve to mediate invasion into the
decidua (Cross, 2000) (Fig. 3). In addition, TGCs assist in
adapting maternal physiology during pregnancy through
luteotrophic and lactogenic hormones (Cross et al., 2002;
Linzer and Fisher, 1999), as well as synthesize angiogenic
factors (Carney et al., 1993; Lee et al., 1988; Voss et al.,
2000), vasodilators (Gagioti et al., 2000; Yotsumoto et al.,
1998), and anticoagulants (Weiler-Guettler et al., 1996)
which likely help to promote local blood flow to the
implantation site.
Of the various trophoblast subtypes formed during
development, the molecular mechanisms regulating TGC
formation are by far the best characterized. Factors known
to maintain the extraembryonic ectoderm (FGF4 and Nodal/
Activin/TGFh) actively suppress TGC formation, and
withdrawal of these factors results in rapid differentiation
into TGCs (Erlebacher et al., 2004; Hughes et al., 2004;
Rossant and Ofer, 1977; Tanaka et al., 1998). As a result,
TGC formation is often considered the Fdefault_ differ-
entiation pathway in the absence of TS cell maintenance.However, TGC differentiation depends upon the coordi-
nated activity of a number of factors, most notably basic
helix–loop–helix transcription factors (bHLH) and their
interacting proteins (Fig. 4).
The bHLH factor Mash2 is expressed within the
ectoplacental cone and is thought to suppress TGC
formation (Cross et al., 1995; Kraut et al., 1998; Scott
et al., 2000), potentially maintaining TGC precursors.
Indeed, overexpression of Mash2 inhibits TGC formation
in vitro, albeit transiently (Cross et al., 1995; Hughes et
al., 2004; Kraut et al., 1998; Scott et al., 2000). Mash2
expression is downregulated as differentiation into TGCs
proceeds (Hughes et al., 2004; Scott et al., 2000) and a
targeted deletion of Mash2 results in a reduction of
ectoplacental cone cells, loss of the subsequent spongio-
trophoblast layer, and a concurrent expansion in TGC
numbers (Guillemot et al., 1995; Guillemot et al., 1994;
Tanaka et al., 1997). The E proteins Alf1 and Itf2, bHLH
factors which interact with Mash2, and the bHLH binding
proteins Id1 and Id2 are also downregulated upon TGC
differentiation (Jen et al., 1997; Scott et al., 2000). Eed, a
polycomb group protein, may be required for repression
of Mash2 during TGC formation as Eed mutants show
ectopic and persistent Mash2 expression and a significant
decrease in secondary TGC differentiation (Wang et al.,
2002).
In contrast to suppressing TGC formation, several factors
are known to directly promote TGC differentiation. The
bHLH transcription factors Hand1 (Cross et al., 1995) and
Stra13 (Hughes et al., 2004) can overcome FGF4/embryonic
fibroblast conditioned medium to promote TGC differ-
entiation (Cross et al., 1995), while deletion of Hand1
results in a block to TGC formation (Riley et al., 1998; Scott
et al., 2000). The bHLH antagonist Imfa promotes TGC
differentiation (Kraut et al., 1998), possibly by inhibiting the
function of Mash2. Thus, an opposing network of bHLH
transcription factors and bHLH interacting proteins regulate
TGC differentiation. In addition to cell intrinsic factors,
extrinsic factors also influence TGC formation. Retinoic
acid, for example, can promote TGC formation both in vitro
and in vivo (Yan et al., 2001), similar to the effects of
overexpression of the retinoic acid responsive gene Stra13
(Hughes et al., 2004).Trophoblast giant cells—origins and subtypes
The mural trophectoderm gives rise to primary TGCs
immediately following implantation, while secondary TGCs
originate from precursors within the ectoplacental cone and
later the spongiotrophoblast (Carney et al., 1993; Johnson
and Rossant, 1981; Rossant et al., 1978) (Fig. 4). Isolated
extraembryonic ectoderm or cultures of TS cells can also
give rise to TGCs in vitro, but not before transiently
expressing markers of ectoplacental cone and spongiotro-
phoblast (Carney et al., 1993; Hughes et al., 2004; Tanaka et
Fig. 3. Histological sections of the mouse placenta and trophoblast subtypes at embryonic days (E) 8.0, 10.5, and 14.5. (A–D) Paraffin sections at E8.0 stained
with H&E. At this stage, the ectoplacental cavity has collapsed, and the chorion, a tightly packed layer of trophoblast stem cells, is in contact with the base of
the ectoplacental cone. The edge of the chorion is covered by mesothelium, a single cell layer derived from embryonic mesoderm. The dotted line demarcates
the outer border of the trophoblast giant cell layer. (E–H) Embryonic day 10.5. Paraffin (E) and semi-thin plastic (F–H) sections stained with H&E and
toluidine blue, respectively. By E10.5, the structure of the mature placenta has begun to form, and the three distinct placental layers can be readily identified.
(I –L) Embryonic day 14.5. Paraffin (I) and semi-thin plastic (J–L) sections stained with H&E and toluidine blue, respectively. By E14.5, numerous glycogen
trophoblast cell clusters can be seen within the spongiotrophoblast layer as well as beyond the trophoblast giant cell layer. The labyrinth layer contains a
considerably higher density of both maternal blood spaces and fetal capillaries. Ch, chorion trophoblast; EPC, ectoplacental cone; f, fetal capillary space;
GlyT, glycogen trophoblast cell; Lab, labyrinth; m, maternal blood sinusoid space; Mes, chorionic mesothelium; SpT, spongiotrophoblast; TGC, trophoblast
giant cell.
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in which trophoblast stem cells first pass through a
progenitor phase characterized by Mash2 and Tpbpa
expression (Carney et al., 1993). While this model is almost
certainly true, this model is based on expression studies of
whole populations of cells and does not preclude the
possibility that some extraembryonic ectoderm cells could
give rise to TGCs directly or through a previously
uncharacterized precursor. In support of this possibility, TS
cells cultured with exogenous retinoic acid readily form
TGCs and can do so without transiently expressing the
ectoplacental/spongiotrophoblast marker Tpbpa/4311 (Yan
et al., 2001). Cell lineage-tracing studies have confirmed the
hypothesis that not all Fsecondary_ trophoblast giant cells are
derived from Tpbpa-positive precursors (A. Fortier and J.C.
Cross, unpublished data).
TGCs display a previously underappreciated level of
sub-specialization (Fig. 4). For example, endovascular
TGCs which invade great distances into the maternal
spiral arteries to replace endothelial cells express Plf but
not Pl1, whereas endovascular TGCs more proximal to
the placenta express both genes (Hemberger et al., 2003).The morphology of endovascular TGCs is also clearly
different to that of interstitial TGCs as they are much
smaller and more spindle-like (Hemberger et al., 2003). In
addition, several genes characteristically expressed in
TGCs are not uniformly expressed in all trophoblast
giant cells, including Mrj (Hunter et al., 1999), Throm-
bomodulin (Weiler-Guettler et al., 1996), and members of
the Cathepsin family (Hemberger et al., 2000). This
indicates the existence of several functionally distinct
subsets of TGCs.Spongiotrophoblast cell differentiation
Spongiotrophoblast cells comprise the middle layer of
the placenta sandwiched between the outer secondary TGCs
and the inner labyrinth layer (Fig. 3). The function of the
spongiotrophoblast layer (or junctional zone) is poorly
understood. However, it could act as structural support for
the developing villous structures of the labyrinth and is also
known to express several unique genes (Cross et al., 2002;
Iwatsuki et al., 2000).
Fig. 4. Trophoblast giant cell origins, differentiation, and subtypes. The gene names in blue text are trophoblast cell subtype specific in their expression. The
gene names in red text indicate genes that promote the differentiation step indicated. The open arrow indicates that retinoic acid (RA) is a cell extrinsic factor
that promotes differentiation.
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ectoplacental cone. However, observations from several
mouse mutants suggest that spongiotrophoblasts and TGCs
can arise from a common ectoplacental cone precursor (Fig.
5). For example, Mash2 has opposing effects on spongio-
trophoblast and TGC development; loss of Mash2 expres-
sion results in loss of the spongiotrophoblast layer and an
increase in secondary TGCs (Guillemot et al., 1994).
Mutations in the Choroideremia (Shi et al., 2004), Cx31
(Plum et al., 2001), and Keratin8/19 (Tamai et al., 2000)
genes also have opposing effects on these two cell types,
indicating that these genes may influence cell fate decisions
in common ectoplacental cone precursors. Interestingly,
formation and/or maintenance of a common ectoplacental
cone precursor population is affected by mutations in p185/
Cul7 or Nodal. Deletion of the p185/Cul7 gene results in a
decrease in both TGCs and spongiotrophoblast cells (Arai et
al., 2003), whereas mice with a hypomorphic allele of
Nodal (Ma et al., 2001) have increased cell numbers in both
these layers. In contrast, mutations in Rap250 (Antonson et
al., 2003) or Hsf1 (Xiao et al., 1999) result in a decrease in
spongiotrophoblast cells without any apparent effect on
TGC number, indicating a role in spongiotrophoblast
differentiation downstream of precursor commitment
(Fig. 5).
Interestingly, genes expressed exclusively in labyrinth
trophoblast can also affect spongiotrophoblast formation.
For example, Ipl, a cytoplasmic adaptor protein, and Esx1,
a homeobox gene, are both expressed in labyrinth cells and
not spongiotrophoblast, but their deletion results in an
expanded spongiotrophoblast layer (Frank et al., 2002; Liand Behringer, 1998). It is unclear how these genes exert
their effects on spongiotrophoblast cells, although it is
certain that a cross-talk exists between these layers within
the placenta.
As with the TGC population, the spongiotrophoblast layer
is not homogenous at the cellular level, and several subtypes
are known to exist. In rats, large numbers of spongiotropho-
blast cells become polyploid by undergoing endoreduplica-
tion during the second half of gestation (Zybina et al., 2000).
It is unknown if any, or at what extent, polyploid spongio-
trophoblast cells exist in mice or if there is any functional
significance of polyploidy. In addition, a unique trophoblast
subtype arises from the spongiotrophoblast layer later in
gestation, the glycogen trophoblast cell, which migrates
great distances into the interstium of the decidua basalis
(Adamson et al., 2002).Glycogen trophoblast cells
Sometime after E12.5, glycogen trophoblast cells begin
to appear in the spongiotrophoblast layer and subsequently
migrate interstitially into the decidua, in some cases well
beyond the boundaries of endovascular TGC invasion
(Adamson et al., 2002) (Fig. 3). In the second half of
gestation, they become the main source of IGF II within the
placenta (Redline et al., 1993). Very little is known about
the molecular regulators of glycogen trophoblast cell
formation or function. Several mouse mutants have shown
a disruption in glycogen trophoblast cell numbers, but
almost always in conjunction with similar defects in the
Fig. 5. Spongiotrophoblast differentiation. Red text denotes genes that affect spongiotrophoblast/TGC common precursor maintenance/formation, cell fate
decisions, or spongiotrophoblast differentiation downstream of precursor cell fate decision. Blue text denotes genes that are expressed within specific placental
compartments or differentiated trophoblast cell subtypes.
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Behringer, 1998), Ipl (Frank et al., 2002), and Pkba (Yang
et al., 2003). By contrast, Igf2 null mice have a dispropor-
tionate loss in glycogen trophoblast cells (Takahashi et al.,
2000), whereas p57kip2 mutant mice have placentomegaly,
with greatly increased numbers of trophoblast cells in the
spongiotrophoblast and labyrinth layers, but, intriguingly,
glycogen trophoblast cells and TGCs are not affected.
Glycogen trophoblast cells therefore share several features
with both TGCs and spongiotrophoblast cells, but they are
clearly unique.Labyrinth trophoblast subtypes
The innermost layer of the mouse placenta, termed the
labyrinth, consists of branched villi that provide a large
surface area for nutrient, waste, and gas exchange and is
composed of trophoblast cells with underlying blood vessels
derived from the allantois (Fig. 3). It is important to
acknowledge, however, that the labyrinth layer does not
contain a homogeneous group of trophoblast cells (Fig. 6).
In fact, the labyrinth contains several distinct trophoblast
subtypes that reside in fixed locations with respect to
maternal and fetal blood spaces. The cells lining the
maternal blood sinusoids are mononuclear trophoblast cellsthat express placental lactogen II, considered a marker of
TGCs (Fig. 7). Adjacent to this cell layer are two layers of
syncytiotrophoblast cells followed by fetal endothelial cells
which are in contact with the fetal blood (Cross, 2000). All
of these cell types can be readily identified based on
position and morphology (Cross, 2000). In addition to the
cells comprising the villi, clusters of Eomes positive cells
can be detected scattered throughout the labyrinth (Wu et
al., 2003). Ehox, another marker of extraembryonic ecto-
derm at E6.5, can also be detected in islands of cells within
the labyrinth layer (Jackson et al., 2003). It would be
interesting to know whether these markers co-localize as it
is tempting to speculate that these cells may represent
labyrinth trophoblast precursors.Syncytiotrophoblast differentiation
Precursors for syncytiotrophoblast most likely reside
within the chorionic plate, based on the fact that many genes
expressed exclusively in the labyrinth are expressed initially
in chorionic trophoblast cells including Gcm1 (Basyuk et
al., 1999), Esx1 (Li and Behringer, 1998), Dlx3 (Morasso et
al., 1999), Tef5 (Jacquemin et al., 1998), and Err2 (Luo et
al., 1997). However, there is no direct evidence of this.
Gcm1 is the only gene known thus far to be specifically
Fig. 7. Trophoblast cell subtypes in the labyrinth layer. (A) Electron
microscopy of E14.5 labyrinth layer. The cells lining the maternal blood
sinusoids (m) are large mononuclear trophoblast cells (Mono). Adjacent to
the mononuclear trophoblast cells are two layers of syncytiotrophoblast
(SynT). Endothelial cells (Endo) line the fetal capillary space (f). Scale
bar = 5 Am. (B) Placental lactogen II immunostaining in E12.5 and E16.5
placenta. PL II immunoreactivity can be detected in the labyrinth layer by
E12.5 in cells lining the maternal blood sinusoids. Cells lining the fetal
blood vessels do not stain for PL II. Note that, by E16.5, all mononuclear
trophoblast cells in the sinusoids express PL II. Brown color is DAB
staining of PL II (1:500 dilution of PL II antibody from Chemicon).
Sections were counterstained with nuclear fast red (Dako). Black
arrowhead = maternal red blood cell; open arrowhead = fetal red blood
cell. Scale bar = 50 Am.
Fig. 6. Differentiation of trophoblast cell subtypes within the labyrinth. Red
text denotes genes that regulate the differentiation step indicated. Blue text
denotes genes that are expressed within specific placental compartments or
differentiated trophoblast cell subtypes.
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(Anson-Cartwright et al., 2000). Gcm1 expression first
appears in equally spaced clusters of cells within the chorion
beginning at E7.5 (Basyuk et al., 1999). By E9.0, after the
allantois has attached to the basal surface of the chorion
(Cross et al., 2003), Gcm1 expressing cell clusters define the
initiation sites for primary branching morphogenesis
(Anson-Cartwright et al., 2000). As branches elongate and
protrude into the chorion, Gcm1 expression is restricted to
the tips of the branches (Anson-Cartwright et al., 2000), and
syncytiotrophoblast cells begin to form (Cross, 2000). In
Gcm1 mutant mice, syncytiotrophoblast formation is
blocked, villous branching morphogenesis is not initiated,
and the chorioallantoic interface remains flat (Anson-Cart-
wright et al., 2000).
Factors directly regulating Gcm1 expression in the
early chorion have not yet been identified. However,
maintenance and further expansion of Gcm1 expression
require contact and signaling with the allantois. Gcm1
expression is dramatically reduced in Mrj mutant mice
which have a failure of chorioallantoic attachment (Hunter
et al., 1999). Furthermore, Hsp90b-deficient mice have a
phenotype that is similar to that of Gcm1 mutants with
failure of branching morphogenesis and labyrinth forma-
tion (Voss et al., 2000). Maintenance and expansion of
Gcm1 expression are lost in these mice (Stecca et al.,
2002), even though Hsp90b is expressed exclusively in
allantoic mesoderm. Thus, initial expression of Gcm1
appears to be independent of chorioallantoic contact, but
subsequent maintenance and expansion of Gcm1 expres-
sion require contact with and signaling from the allantois
(Stecca et al., 2002).Syncytiotrophoblast formation is a two-step process
involving first cell cycle exit and then subsequent fusion
of these cells to form a syncytium. Gcm1 regulates the
initiation of syncytiotrophoblast formation as ectopic
expression of Gcm1 in TS cells in vitro promotes cell
cycle exit (Hughes et al., 2004) and Gcm1-deficient mice
have a block in syncytiotrophoblast formation (Anson-
Cartwright et al., 2000). In addition, Rb-deficient mice
have excessive proliferation in the labyrinth layer and
show a relative decrease in syncytiotrophoblast formation
(Wu et al., 2003), indicating that cell cycle exit is critical
for syncytiotrophoblast formation. Very little is known
D.G. Simmons, J.C. Cross / Developmental Biology 284 (2005) 12–24 21about the process of trophoblast cell–cell fusion in mice.
In humans, however, trophoblast fusion is thought to be
mediated by Syncytin, a transmembrane protein encoded
by an endogenous retrovirus (Mi et al., 2000). When
Syncytin is ectopically expressed in cells, it can mediate
fusion even if it is expressed in only one of the two cells,
inferring that fusion is asymmetric and involves unequal
partners (Mi et al., 2000). Importantly, GCM1 can
regulate the Syncytin promoter (Yu et al., 2002). Recently,
homologues of human Syncytin and Syncytin2 (Blaise et
al., 2003) have been identified in mice (Dupressoir et al.,
2005). They are expressed in the labyrinth layer of the
murine placenta from E9.5 and have been shown to
trigger cell fusion in cultured cells (Dupressoir et al.,
2005). Whether they are regulated by Gcm1 is currently
unknown.Concluding remarks
Much progress has been made in recent years towards
understanding the molecular mechanisms governing
trophoblast development and the subsequent differentia-
tion of the various trophoblast subtypes comprising the
placenta. This comes mainly through the generation of a
large number of mutant mice, as well as the identification
of trophoblast subtype specific markers. It is now clear
that the trophoblast lineage comprises a previously
underappreciated diversity of subtypes. In the future, a
more detailed analysis of mouse mutants with defects in
placental development and how they influence the various
trophoblast subtype populations would greatly enhance
our knowledge of the mechanisms of trophoblast differ-
entiation. The derivation of trophoblast stem cells in vitro
has proved invaluable to our understanding of trophoblast
stem cell maintenance and subtype specialization and will
continue to be a powerful tool to provide further insights
into the regulation of trophoblast proliferation and
differentiation.References
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